2024-09-18 - Analysis Report
## CVS Health Corporation Stock Analysis

**Company Overview:** CVS Health Corporation is a healthcare company that operates pharmacies, drugstores, and healthcare services. 

**Performance Analysis:**

**1.  Performance vs. S&P 500:**

* CVS has experienced a cumulative return of -20.58%, significantly lagging behind the S&P 500 (VOO) with a return of 88.56%. 
* The relative divergence (measuring the performance gap) currently stands at -109.14, which is 1.37% of the maximum divergence range. This indicates that CVS has consistently underperformed the S&P 500 over the analyzed period.

**2.  Recent Price Movements:**

* Closing price: $57.68
* 5-day moving average: $57.53
* 20-day moving average: $57.75
* 60-day moving average: $58.37

The stock is currently trading slightly below its 20-day moving average, suggesting potential downward pressure in the short term.  However, it's important to note that the 5-day moving average is below the 20-day moving average, indicating potential short-term support.

**3.  Technical Indicators:**

* RSI: 51.11, indicating neutral sentiment, neither overbought nor oversold.
* PPO: 0.15, suggesting a slight upward trend, although this could be a short-term signal.
* Delta_Previous_Relative_Divergence: -0.72, indicating a recent decrease in relative divergence compared to the previous period. This signifies a potential short-term decline in performance relative to the market.
* Expected_Return: 12.45%, representing the potential maximum return over the next 5 years. 

**4.  Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

CVS's most recent earnings report for the quarter ending August 7, 2024, came in slightly above expectations. However, the company has consistently missed earnings estimates for the previous quarters. This suggests potential challenges in maintaining consistent growth in the coming periods.

**5.  Overall Analysis:**

CVS Health Corporation is currently underperforming the broader market, lagging behind the S&P 500 by a significant margin. Although the stock is currently trading near its 20-day moving average, the recent trend suggests potential short-term downward pressure. Technical indicators offer a mixed outlook, with RSI indicating neutrality and PPO suggesting slight upside potential. However, the recent decrease in relative divergence points towards a potential short-term decline in performance. While the most recent earnings report surpassed expectations, the company has faced challenges in consistently meeting estimates in the past. 

**6.  Investment Recommendation:**

Based on the current analysis, CVS Health Corporation presents a risky investment proposition.  The company's underperformance compared to the market, coupled with the mixed technical signals, suggests a cautious approach. While the stock has potential for growth based on its expected return, it's crucial to monitor future earnings reports and market trends closely before making any investment decisions.